An Effective Method to Measure Disease Similarity Using Gene and Phenotype Associations

Essential genes identification model based on sequence feature map and graph convolutional neural network

BACKGROUND

Essential genes encode functions that play a vital role in the life activities of organisms, encompassing growth, development, immune system functioning, and cell structure maintenance. Conventional experimental techniques for identifying essential genes are resource-intensive and time-consuming, and the accuracy of current machine learning models needs further enhancement. Therefore, it is crucial to develop a robust computational model to accurately predict essential genes.

RESULTS

In this study, we introduce GCNN-SFM, a computational model for identifying essential genes in organisms, based on graph convolutional neural networks (GCNN). GCNN-SFM integrates a graph convolutional layer, a convolutional layer, and a fully connected layer to model and extract features from gene sequences of essential genes. Initially, the gene sequence is transformed into a feature map using coding techniques. Subsequently, a multi-layer GCN is employed to perform graph convolution operations, effectively capturing both local and global features of the gene sequence. Further feature extraction is performed, followed by integrating convolution and fully-connected layers to generate prediction results for essential genes. The gradient descent algorithm is utilized to iteratively update the cross-entropy loss function, thereby enhancing the accuracy of the prediction results. Meanwhile, model parameters are tuned to determine the optimal parameter combination that yields the best prediction performance during training.

CONCLUSIONS

Experimental evaluation demonstrates that GCNN-SFM surpasses various advanced essential gene prediction models and achieves an average accuracy of 94.53%. This study presents a novel and effective approach for identifying essential genes, which has significant implications for biology and genomics research.

Molecular bases of comorbidities: present and future perspectives

Co-occurrence of diseases decreases patient quality of life, complicates treatment choices, and increases mortality. Analyses of electronic health records present a complex scenario of comorbidity relationships that vary by age, sex, and cohort under study. The study of similarities between diseases using 'omics data, such as genes altered in diseases, gene expression, proteome, and microbiome, are fundamental to uncovering the origin of, and potential treatment for, comorbidities. Recent studies have produced a first generation of genetic interpretations for as much as 46% of the comorbidities described in large cohorts. Integrating different sources of molecular information and using artificial intelligence (AI) methods are promising approaches for the study of comorbidities. They may help to improve the treatment of comorbidities, including the potential repositioning of drugs.

An Integrative Disease Information Network Approach to Similar Disease Detection

Disease similarity analysis impacts significantly in pathogenesis revealing, treatment recommending, and disease-causing genes predicting. Previous works study the disease similarity based on the semantics obtaining from biomedical ontologies (e.g., disease ontology) or the function of disease-causing molecules. However, such methods almost focus on a single perspective for obtaining disease features, which may lead to biased results for similar disease detection. To address this issue, we propose a disease information network-based integrative approach named MISSION for detecting similar diseases. By leveraging the associations between diseases and other biomedical entities, the disease information network is established first. Then, the disease similarity features extracted from the aspects of disease taxonomy, attributes, literature, and annotations are integrated into the disease information network. Finally, the top-k similar disease query is performed based on the integrative disease information. The experiments conducted on real-world datasets demonstrate that MISSION is effective and useful in similar disease detection.

Enhanced disease-disease association with information enriched disease representation

OBJECTIVE

Quantification of disease-disease association (DDA) enables the understanding of disease relationships for discovering disease progression and finding comorbidity. For effective DDA strength calculation, there is a need to address the main challenge of integration of various biomedical aspects of DDA is to obtain an information rich disease representation.

MATERIALS AND METHODS

An enhanced and integrated DDA framework is developed that integrates enriched literature-based with concept-based DDA representation. The literature component of the proposed framework uses PubMed abstracts and consists of improved neural network model that classifies DDAs for an enhanced literature-based DDA representation. Similarly, an ontology-based joint multi-source association embedding model is proposed in the ontology component using Disease Ontology (DO), UMLS, claims insurance, clinical notes etc. Results and Discussion: The obtained information rich disease representation is evaluated on different aspects of DDA datasets such as Gene, Variant, Gene Ontology (GO) and a human rated benchmark dataset. The DDA scores calculated using the proposed method achieved a high correlation mainly in gene-based dataset. The quantified scores also shown better correlation of 0.821, when evaluated on human rated 213 disease pairs. In addition, the generated disease representation is proved to have substantial effect on correlation of DDA scores for different categories of disease pairs.

CONCLUSION

The enhanced context and semantic DDA framework provides an enriched disease representation, resulting in high correlated results with different DDA datasets. We have also presented the biological interpretation of disease pairs. The developed framework can also be used for deriving the strength of other biomedical associations.

MGREL: A multi-graph representation learning-based ensemble learning method for gene-disease association prediction

The identification of gene-disease associations plays an important role in the exploration of pathogenic mechanisms and therapeutic targets. Computational methods have been regarded as an effective way to discover the potential gene-disease associations in recent years. However, most of them ignored the combination of abundant genetic, therapeutic information, and gene-disease network topology. To this end, we re-organized the current gene-disease association benchmark dataset by extracting the newest gene-disease associations from the OMIM database. Then, we developed a multi-graph representation learning-based ensemble model, named MGREL to predict gene-disease associations. MGREL integrated two feature generation channels to extract gene and disease features, including a knowledge extraction channel which learned high-order representations from genetic and therapeutic information, and a graph learning channel which acquired network topological representations through multiple advanced graph representation learning methods. Then, an ensemble learning method with 5 machine learning models was used as the classifier to predict the gene-disease association. Comprehensive experiments have demonstrated the significant performance achieved by MGREL compared to 5 state-of-the-art methods. For the major measurements (AUC = 0.925, AUPR = 0.935), the relative improvements of MGREL compared to the suboptimal methods are 3.24%, and 2.75%, respectively. MGREL also achieved impressive improvements in the challenging tasks of predicting potential associations for unknown genes/diseases. In addition, case studies implied potential applications for MGREL in the discovery of potential therapeutic targets.

GOntoSim: a semantic similarity measure based on LCA and common descendants

The Gene Ontology (GO) is a controlled vocabulary that captures the semantics or context of an entity based on its functional role. Biomedical entities are frequently compared to each other to find similarities to help in data annotation and knowledge transfer. In this study, we propose GOntoSim, a novel method to determine the functional similarity between genes. GOntoSim quantifies the similarity between pairs of GO terms, by taking the graph structure and the information content of nodes into consideration. Our measure quantifies the similarity between the ancestors of the GO terms accurately. It also takes into account the common children of the GO terms. GOntoSim is evaluated using the entire Enzyme Dataset containing 10,890 proteins and 97,544 GO annotations. The enzymes are clustered and compared with the Gold Standard EC numbers. At level 1 of the EC Numbers for Molecular Function, GOntoSim achieves a purity score of 0.75 as compared to 0.47 and 0.51 GOGO and Wang. GOntoSim can handle the noisy IEA annotations. We achieve a purity score of 0.94 in contrast to 0.48 for both GOGO and Wang at level 1 of the EC Numbers with IEA annotations. GOntoSim can be freely accessed at (http://www.cbrlab.org/GOntoSim.html).

Biomedical data, computational methods and tools for evaluating disease-disease associations

In recent decades, exploring potential relationships between diseases has been an active research field. With the rapid accumulation of disease-related biomedical data, a lot of computational methods and tools/platforms have been developed to reveal intrinsic relationship between diseases, which can provide useful insights to the study of complex diseases, e.g. understanding molecular mechanisms of diseases and discovering new treatment of diseases. Human complex diseases involve both external phenotypic abnormalities and complex internal molecular mechanisms in organisms. Computational methods with different types of biomedical data from phenotype to genotype can evaluate disease-disease associations at different levels, providing a comprehensive perspective for understanding diseases. In this review, available biomedical data and databases for evaluating disease-disease associations are first summarized. Then, existing computational methods for disease-disease associations are reviewed and classified into five groups in terms of the usages of biomedical data, including disease semantic-based, phenotype-based, function-based, representation learning-based and text mining-based methods. Further, we summarize software tools/platforms for computation and analysis of disease-disease associations. Finally, we give a discussion and summary on the research of disease-disease associations. This review provides a systematic overview for current disease association research, which could promote the development and applications of computational methods and tools/platforms for disease-disease associations.

Jointly Integrating VCF-Based Variants and OWL-Based Biomedical Ontologies in MongoDB

The development of the next-generation sequencing (NGS) technologies has led to massive amounts of VCF (Variant Call Format) files, which have been the standard formats developed with 1000 Genomes Project. At the same time, with the widespread use of biomedical ontologies in the biomedical community, more and more applications have accepted the Web Ontology Language (OWL) as the dominant data format for the specifications of biomedical ontology descriptions, leading to the rapid growth of OWL-based biomedical ontology scale. In this paper, we seek to explore an effective method for the management of VCF-based genetic variants and OWL-based biological ontologies using the MongoDB database. Considering many current applications (such as the short genetic variations database dbSNP, etc.) are transitioning to the new design by using JSON (JavaScript Object Notation) to support future massive data expansion and interchanges. We firstly propose a series of rules for the mapping from VCF and OWL files to JSON files, and then present rule-based algorithms for transforming VCF-based genetic variants and OWL-based biological ontologies into JSON objects. On this basis, we introduce effective approaches of integrating the mapped JSON files in MongoDB. Finally, we complement this work with a set of experiments to show the performance of our proposed approaches. The source code of the proposed approaches could be freely available at https://github.com/lyotvincent/AJIA.

Evaluation of standard and semantically-augmented distance metrics for neurology patients

Background

Patient distances can be calculated based on signs and symptoms derived from an ontological hierarchy. There is controversy as to whether patient distance metrics that consider the semantic similarity between concepts can outperform standard patient distance metrics that are agnostic to concept similarity. The choice of distance metric can dominate the performance of classification or clustering algorithms. Our objective was to determine if semantically augmented distance metrics would outperform standard metrics on machine learning tasks.

Methods

We converted the neurological findings from 382 published neurology cases into sets of concepts with corresponding machine-readable codes. We calculated patient distances by four different metrics (cosine distance, a semantically augmented cosine distance, Jaccard distance, and a semantically augmented bipartite distance). Semantic augmentation for two of the metrics depended on concept similarities from a hierarchical neuro-ontology. For machine learning algorithms, we used the patient diagnosis as the ground truth label and patient findings as machine learning features. We assessed classification accuracy for four classifiers and cluster quality for two clustering algorithms for each of the distance metrics.

Results

Inter-patient distances were smaller when the distance metric was semantically augmented. Classification accuracy and cluster quality were not significantly different by distance metric.

Conclusion

Although semantic augmentation reduced inter-patient distances, we did not find improved classification accuracy or improved cluster quality with semantically augmented patient distance metrics when applied to a dataset of neurology patients. Further work is needed to assess the utility of semantically augmented patient distances.